AstraZeneca Group RSS feed
http://www.thisislondon.co.uk/standard/related-36769-astrazeneca-group/topic-rss.do
AstraZeneca Group RSS feedAstra faces 6000 side-effects claims over mind drug
http://www.thisislondon.co.uk/standard-business/article-23771619-astra-faces-6000-side-effects-claims-over-mind-drug.do
AstraZeneca could face as many as 6000 lawsuits after a judge in America ruled that claims against its psychiatric treatment Seroquel should be put on trial separately2009-11-19T08:55:34ZWhy are we getting so stressed?
http://www.thisislondon.co.uk/health/article-23771117-why-are-we-getting-so-stressed.do
It's reaching epidemic proportions in London and is the number one reason for absence from work. Sophie Goodchild looks at why we are getting so stressed2009-11-18T12:29:12ZMetals add lustre to miners as dollar is in the doldrums
http://www.thisislondon.co.uk/standard-business/article-23766680-metals-add-lustre-to-miners-as-dollar-is-in-the-doldrums.do
The price of gold traded at a record high of $1108.00 an ounce on world markets today in response to a weaker dollar2009-11-09T13:31:29ZGold adds sparkle to miners as dollar’s in the doldrums
http://www.thisislondon.co.uk/standard-business/article-23766485-gold-adds-sparkle-to-miners-as-dollars-in-the-doldrums.do
The price of gold traded at a new record high of $1,107.12 an ounce on world markets today, in response to a weaker dollar2009-11-09T08:53:37ZFlu drug firms Glaxo and AstraZeneca under fire in US for ‘price fixing’
http://www.thisislondon.co.uk/standard-business/article-23764087-british-flu-drug-firms-under-fire-in-us-for-price-fixing.do
GlaxoSmithKline and fellow British drugmaker AstraZeneca were today accused of price-fixing on their seasonal flu vaccines (SFV) by one of the US's top prosecutors2009-11-04T07:46:09ZLloyds' shares leap as it looks to avoid toxic debt scheme
http://www.thisislondon.co.uk/standard-business/article-23762633-yell-shares-surge-as-rescue-deal-gets-nod-from-lenders.do
"Far from cheap, but no longer expensive." That was the view of Credit Suisse on Lloyds Banking Group2009-10-30T08:54:39ZAstraZeneca cashes in on swine-flu vaccine
http://www.thisislondon.co.uk/standard-business/article-23762299-astrazeneca-cashes-in-on-swine-flu-vaccine.do
Pharma-giant AstraZeneca today jumped on the swine flu bonanza bandwagon, with H1N1 vaccine sales helping it raise annual profit forecasts2009-10-29T12:44:00ZAstraZeneca shares get a boost from some heavyweight backing
http://www.thisislondon.co.uk/standard-business/article-23738743-astrazeneca-shares-get-a-boost-from-some-heavyweight-backing.do
Drugs giant AstraZeneca was showing the rest of the top 100 companies a clean pair of heels, spurred on by recommendations from two of the City’s biggest players2009-09-01T12:49:12ZLondon shares go bowling along as global worries ease
http://www.thisislondon.co.uk/standard-business/article-23734668-london-shares-go-bowling-along-as-global-worries-ease.do
Some of the confidence being shown by stock-market investors rubbed off on the England cricket team in the fifth and final Test at the Brit Oval2009-08-20T07:52:23ZWatchdog delays UK debut of Astra swine flu treatment
http://www.thisislondon.co.uk/standard-business/article-23726209-watchdog-delays-uk-debut-of-astra-swine-flu-treatment.do
Britons will have to wait for a pioneering line of defence against swine flu according to AstraZeneca, which admitted its H1N1 vaccine has been hit by delays2009-07-30T12:53:47ZDrug research leaves Astra with a headache
http://www.thisislondon.co.uk/standard-business/article-23718680-drug-research-leaves-astra-with-a-headache.do
British drug giant AstraZeneca was today suffering the ill effects of medical research that criticised Seroquel, a schizophrenia medicine that is the pharma firm's second best-selling product2009-07-13T07:52:38ZHeritage Oil on a rocky ride in fundraising to buy Genel
http://www.thisislondon.co.uk/standard-business/article-23707584-heritage-oil-on-a-rocky-ride-in-fundraising-to-buy-genel.do
Shares of Heritage Oil hit a low for the day of 510p before rebounding with a rise of 26½p to 532p after announcing plans to raise up to £137 million to help finance the proposed acquisition of Genel Energy International2009-06-15T08:21:06ZAstraZeneca’s Seroquel gets closer to a green light in US
http://www.thisislondon.co.uk/standard-business/article-23706228-astrazenecas-seroquel-gets-closer-to-a-green-light-in-us.do
Pharmaceuticals giant AstraZeneca received a boost when the US drug watchdog took the first steps to approve its $4.5 billion anti-psychotic medicine Seroquel for use by children2009-06-11T06:18:42ZLong, profitable life of vaccines means it's not just the ill clamouring for them
http://www.thisislondon.co.uk/standard-business/article-23701881-long-profitable-life-of-vaccines-means-its-not-just-the-ill-clamouring-for-them.do
A dirty-brown brick building close to Northern Line station Mill Hill East is an unlikely place to find the saviour of the pharmaceuticals industry2009-06-01T07:35:24ZAstraZeneca setback as US limits use of big-selling drug
http://www.thisislondon.co.uk/standard-business/article-23674083-astrazeneca-setback-as-us-limits-use-of-big-selling-drug.do
AstraZeneca has been told by the US Food and Drug Administration that its second biggest-selling drug should not be used as a major treatment for depression2009-04-09T08:20:25ZAstra suffers asthma drug setback in US
http://www.thisislondon.co.uk/standard-business/article-23672108-astra-suffers-asthma-drug-setback-in-us.do
Britain's second-largest drugs firm, AstraZeneca, was hit by delays in its bid to boost sales of its asthma drug Symbicort in the US2009-04-06T07:52:00ZHeadache for drug giants as US cuts medical spend
http://www.thisislondon.co.uk/standard-business/article-23654414-headache-for-drug-giants-as-us-cuts-medical-spend.do
2009-02-27T09:51:54ZObama drug price plans spook European pharma investors
http://www.thisislondon.co.uk/standard-business/article-23654738-obama-drug-price-plans-spook-european-pharma-investors.do
<strong>pharmaceuticals: </strong> European drug stocks tumbled after Barack Obama targeted high drug prices in his 2010 budget, underlining the importance of U.S. sales to companies based in Basel, London and Paris2009-02-27T12:21:08ZAstraZeneca shedding 6000 jobs
http://www.thisislondon.co.uk/standard-business/article-23631466-astrazeneca-shedding-6000-jobs.do
<strong>Health: </strong> Pharmaceuticals giant AstraZeneca is axeing 6000 jobs worldwide after the company forecast no sales growth in 20092009-01-29T14:22:45ZXstrata leads the way amid talk of a cash-calls torrent
http://www.thisislondon.co.uk/standard-business/article-23631053-xstrata-leads-the-way-amid-talk-of-a-cash-calls-torrent.do
2009-01-29T09:28:24ZAs patents run out, drug firms need to find a new Viagra
http://www.thisislondon.co.uk/standard-business/article-23614533-as-patents-run-out-drug-firms-need-to-find-a-new-viagra.do
<strong>Analysis: </strong> The head of Pfizer, the world's largest drug company, this week set the pharmaceutical industry alight with talk of a megadeal when he revealed a shopping list of rivals in his sights2009-01-08T10:21:33ZHousebuilders fall 85% to be worst sector of year
http://www.thisislondon.co.uk/standard-business/article-23609907-housebuilders-fall-85-to-be-worst-sector-of-year.do
<strong>Markets:</strong> Housebuilding shares closed down 85% on the year, making it the worst 12 months in the sector's history2008-12-31T09:22:59ZMarket report: Debt-heavy 3i dives to another new low
http://www.thisislondon.co.uk/standard-business/article-23607783-market-report-debt-heavy-3i-dives-to-another-new-low.do
Two years ago the fortunes of private-equity companies were riding high, but not any more. The credit crunch and subsequent stock market crash have made life difficult for the likes of 3i Group, which saw its shares slump to yet another new low today.2008-12-24T09:23:19ZBitter pill as drugs giant AstraZeneca chops workers
http://www.thisislondon.co.uk/standard-business/article-23589983-bitter-pill-as-drugs-giant-astrazeneca-chops-workers.do
<strong>Pharmaceuticals:</strong> Drugs giant AstraZeneca is axeing 250 UK jobs as part of a plan to shed 1400 worldwide2008-11-20T10:30:30ZMarket report: Lonmin backers are left to rue missed chance
http://www.thisislondon.co.uk/standard-business/article-23584333-market-report-lonmin-backers-are-left-to-rue-missed-chance.do
Shareholders of South African miner Lonmin were today again contemplating what might have been had they agreed to the offer from Xstrata earlier this year.2008-11-10T09:11:12ZFootsie boost as the hot money favours miners
http://www.thisislondon.co.uk/standard-business/article-23532448-footsie-boost-as-the-hot-money-favours-miners.do
2008-08-14T08:25:40ZAstra in court win over patent
http://www.thisislondon.co.uk/standard-business/article-23505266-astra-in-court-win-over-patent.do
Drugs giant AstraZeneca has won the latest round in a US court battle over the patent for its blockbuster schizophrenia drug Seroquel2008-07-02T10:13:11ZD-day for Astra on blockbuster
http://www.thisislondon.co.uk/standard-business/article-23497918-d-day-for-astra-on-blockbuster.do
Drug firm AstraZeneca is due to find out today the fate of its case against generic drug maker Teva Pharmaceutical Industries in the fight to protect its blockbuster drug Seroquel2008-06-23T10:22:09ZGlaxo lung drug gets a US boost
http://www.thisislondon.co.uk/standard-business/article-23481656-glaxo-lung-drug-gets-a-us-boost.do
US health regulators say GSK's Advair medicine is safe and effective for the wider treatment of patients with the lung disease COPD2008-05-01T15:23:13ZAstra finds new use for its blockbuster
http://www.thisislondon.co.uk/standard-business/article-23469332-astra-finds-new-use-for-its-blockbuster.do
Drugs giant AstraZeneca claims a breakthrough in the prevention of heart attacks2008-03-31T10:43:57Z